
    
      In the tretament phase, 5 treatments administered were oxycodone HCl/niacin tablets as
      follows: (A) 40/0 mg, (B) 80/0 mg, (C) (40/240 mg, (D) 80/480 mg and (E) 0/0 mg. Each
      treatment was administered as a single dose of 8 tablets once a day at approximately the same
      time each day. All doses were given with water, and all 8 tablets were to be swallowed in 5
      minutes. Doses were separated by 48 (Â± 1) hours. All subjects received each treatment in a
      randomized sequence using a Williams design.
    
  